This announcement is a separate document:
富祥药业:2023年富祥药业营业收入扣除情况表的鉴证报告
Jiangxi Fushine Pharmaceutical: Verification Report on the 2023 Fuxiang Pharmaceutical Revenue Deduction Status Table
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.